| 431 |
AVASTIN 100 MG/4 ML |
BEVACIZUMAB 100 MG / 4ML |
SOLUTION FOR INFUSION |
VIAL |
- METASTATIC COLORECTAL CANCER
- LOCALLY RECURRENT OR METASTATIC BREAST CANCER.
- ADVANCED,METASTATIC OR RECURRENT NON SMALL CELL LUNG CANCER.
- ADVANCED AND/OR METASTATIC RENAL CELL CANCER.
- MALIGNANT GLIOMA ( WHO GRADE IV) GLIOBLASTOMA.
- EPITHELI |
No |
DKSH LAOS COMPANY LIMITED |
ROCHE DIAGNOSTICS GMBH |
GERMANY |
CERTIFICATE RELEASED |
07 I 3868/13 |
2023-03-31 |
2026-03-30 |
View |
| 432 |
AVASTIN 100 MG/4 ML |
BEVACIZUMAB 100 MG/4ML |
SOLUTION FOR INFUSION |
VIAL |
METASTATIC COLORECTAL CANCER; LOCALLY RECURRENT OR METASTATIC BREAST CANCER; ADVANCED, METASTATIC OR RECURRENT NON SMALL CELL LUNG CANCER; ADVANCED AND/OR METASTATIC RENAL CELL CANCER… |
Yes |
DKSH LAOS COMPANY LIMITED |
F.HOFFMANN LA ROCHE LTD. |
SWITZERLAND |
CERTIFICATE RELEASED |
06 I 3125/08 |
2022-07-22 |
2025-07-21 |
View |
| 433 |
AVASTIN 400 MG/16 ML |
BEVACIZUMAB 400 MG/16 ML |
SOLUTION FOR INFUSION |
VIAL |
- METASTATIC COLORECTAL CANCER.
- LOCALLY RECURRENT OR METASTATIC BREAST CANCER.
- ADVANCED, METASTATIC OR RECURRENT NON
SMALL CELL LUNG CANCER
- ADVANCED AND /OR METASTATIC RENAL CELL CANCER.
- MALIGNANT GLIOMA( WHO GRADE IV) GLIOBLASTOMA.
- EPITHE |
No |
DKSH LAOS COMPANY LIMITED |
ROCHE DIAGNOSTICS GMBH |
GERMANY |
CERTIFICATE RELEASED |
07 I 3869/13 |
2023-03-31 |
2026-03-30 |
View |
| 434 |
AVASTIN 400 MG/16 ML |
BEVACIZUMAB 400 MG/16 ml |
SOLUTION FOR INFUSION |
VIAL |
METASTATIC COLORECTAL CANCER, LOCALLY RECURRENT OR METASTATIC BREAST CANCER; ADVANCED, METASTATIC OR RECURRENT NON SMALL CELL LUNG CANCER; ADVANCED AND /OR METASTATIC RENAL CELL CANCER |
Yes |
DKSH LAOS COMPANY LIMITED |
F.HOFFMANN LA ROCHE LTD. |
SWITZERLAND |
CERTIFICATE RELEASED |
06 I 3124/08 |
2022-07-22 |
2025-07-21 |
View |
| 435 |
BETEX |
THIAMINE HCL 100MG, PYRIDOXINE HCL 200MG, CYANOCOBALAMIN 200MCG |
TABLET |
ALUMINIUM FOIL |
VITAMIN B1, B6, B12 DEFICIENCY, NEURITIS AND OTHER DISORDERS ASSOCIATED WITH B1, B6, B12 |
No |
DKSH LAOS COMPANY LIMITED |
THE UNITED DRUG (1996) CO.,LTD. |
THAILAND |
CERTIFICATE RELEASED |
08 I 2109/02 |
2023-03-31 |
2026-03-30 |
View |
| 436 |
BETEX DN |
METHYLCOBALAMIN USP 1500 MCG, ALPHA LIPOIC ACID USP 300 MG, PYRIDOXINE HYDROCHLORIDE BP 10 MG, FOLIC ACID BP 1.5 MG, THIAMINE NITRATE BP 100 MG |
CAPSULE |
ALU-ALU BLISTERPACK |
MAINTAIN HEALTHY NERVOUS SYSTEM, NORMALISE EVERY SYSTEM IN THE HUMAN BODY, AIDS IN REPLENISHING BLOOD LEVELS IN THE BODY, PROMOTHES ENERGY METABOLISM, PREVENTS PRIMARY BIRTH DEFECTS IN PREGNANT WOMEN |
No |
DKSH LAOS COMPANY LIMITED |
NOVAGEN HEALTHCARE PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5676/24 |
2024-02-06 |
2027-02-05 |
View |
| 437 |
BETEX STRES |
VITAMIN B1 BP 50 MG, VITAMIN B2 BP 25 MG, VITAMIN B6 BP 10 MG, VITAMIN B12 BP 500 MCG, VITAMIN C BP 50 MG, NICOTINAMIDE BP 50 MG, CALCIUM PANTOTHENATE BP 20 MG, ZINC 15 MG |
FILM COATED TABLET |
ALU-ALU BLISTERPACK |
PROVIDED THE BODY WITH OPTIMUM ENERGY BUILD UP AND STRENTHENS THE BODY DEFENSE AGAINST STRESS AS IN PEROID OF RAPID GROWTH AND DEVELOPMENT, PHYSICAL AND MENTAL STRAINS, PREGNANCY AND LACTATION, FEBRILE AND TOXIC CONDITION, TRAUMATIC INJURIES |
No |
DKSH LAOS COMPANY LIMITED |
NOVAGEN HEALTHCARE PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5677/24 |
2024-02-06 |
2027-02-05 |
View |
| 438 |
BETEX VITAMIN DROPS |
EACH 0.6 ML CONTAINS: VITAMIN A BP (AS PALMITATE) 3000 IU, VITAMIN B2 1 MG (AS RIBOFLAVIN SODIUM PHOSPHATE BP EQ.TO RIBOFLAVIN), VITAMIN E ( ALPHA TOCOPHERYL ACETATE BP) 5 MG, VITAMIN B1 (THIAMINE NITRATE BP) 2 MG, VITAMIN B6 BP 1 MG, VITAMIN C BP 40 MG, VITAMIN D3 BP 400 IU, NICOTINAMIDE BP 10 MG, DEXPANTHENOL BP 3 MG |
SOLUTION |
GLASS BOTTLE |
FOR THE TREATMENT OF THE VITAMIN DEFICIENCY STATE, VITAMIN E PROVIDES IN THE DROPS IS PARTICULARLY USEFUL IN THE TREATMENT OF PREMATURE OR LOW BIRTH WEIGHT INFANTS |
No |
DKSH LAOS COMPANY LIMITED |
NOVAGEN HEALTHCARE PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5678/24 |
2024-02-06 |
2027-02-05 |
View |
| 439 |
BEZARTAN TABLET 150 MG |
IRBESARTAN 150 MG |
FILM COATED TABLET |
PVDC-BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION, TREATMENT OF DIABETIC NEPHROPATHY WITH AN ELEVATED SERUM CREATININE AND PROTEINURIA (>300 MG/DAY) IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION |
No |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA MANUFACTURING(BANGI)SDN.BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 5475/23 |
2023-04-25 |
2026-04-24 |
View |
| 440 |
BEZARTAN TABLET 300 MG |
IRBESARTAN 300 MG |
FILM COATED TABLET |
PVDC-BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION, TREATMENT OF DIABETIC NEPHROPATHY WITH AN ELEVATED SERUM CREATININE AND PROTEINURIA (>300 MG/DAY) IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION |
No |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA MANUFACTURING(BANGI)SDN.BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 5476/23 |
2023-04-25 |
2026-04-24 |
View |
